Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Drug Repositioning Approach to Target Viral and Host Cells in Terms of Covid-19 Treatment: A Review of in Vivo Experiments and Clinical Studies Publisher



Shahali A1, 2, 3 ; Akbari V1 ; Soltani R4 ; Badri SS4 ; Ardeshir RA5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran
  3. 3. Department of Pharmaceutics, College of Pharmacy, University of the Punjab, Lahore, Pakistan
  4. 4. Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Faculty of Biotechnology, Amol University of Special Modern Technologies, Amol, Iran

Source: Journal of Experimental and Clinical Medicine (Turkey) Published:2022


Abstract

While the COVID-19 pandemic is expanding at an alarming rate, there is currently no treatment option for this disease. Therefore, it is necessary to find an effective treatment special for hospitalized COVID-19 patients at the earliest possible time. One of the promising options which should be investigated is the possible effects of old drugs or drug repositioning. This strategy has less risk with more economic advantages and can benefit the long-term control of this pandemic. Our study aimed to give an overview, update the current status of drug candidates (both virus-targeting and host-targeting drugs) for repurposing in COVID-19 infection, and assess the possible mechanism of their effect, in vivo antiviral efficacy, and clinical studies. © 2022 Ondokuz Mayis Universitesi. All rights reserved.
Other Related Docs
10. Corticosteroid Therapy for 2019 Novel Coronavirus: Lessons From Sars and Mers, Avicenna Journal of Clinical Microbiology and Infection (2021)
11. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
16. Potential Treatments for Covid-19; a Narrative Literature Review, Archives of Academic Emergency Medicine (2020)
26. Emerging Technologies for the Treatment of Covid-19, Advances in Experimental Medicine and Biology (2021)
32. Androgens' Role in Severity and Mortality Rates of Covid-19, Hormone and Metabolic Research (2022)
33. Hepatic Disorders and Covid-19: From Pathophysiology to Treatment Strategy, Canadian Journal of Gastroenterology and Hepatology (2022)
40. Cytokines and Micrornas in Sars-Cov-2: What Do We Know?, Molecular Therapy Nucleic Acids (2022)
43. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
47. Covid-19 Management in the Emergency Ward, Journal of Research in Medical Sciences (2021)
48. Recent Findings of Coronavirus: The Pathogenesis and Treatment, Journal of Isfahan Medical School (2020)